BPC-157 has been shown in animal studies to adhere to the metabolic process of standard peptide-based drugs, suggesting that injections are the most bioavailable route of BPC-157 administration [30, 31]
It's approved as a pharmaceutical drug in Germany, Austria, Russia, China, and much of Eastern Europe for stroke recovery and dementia treatment
In addition to its skin benefits, glutathione strengthens the immune system by promoting lymphocyte proliferation, essential for a robust immune response
Discordance studies have consistently shown that ApoB and LDL particle number can identify risk not fully captured by LDL-C
Consistent timing enhances the peptide's bioavailability and benefits
PMID: 14722139 DOI: 10.1001/jama.291.2.182-a Shih ML et al (1994): Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents